CONMED CORPORATION Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax
CONMED CORPORATION (CNMD) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax of $551.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax · last filed 2026-07-29
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2026-06-30 was $551.00K.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-12-31 was $32.00K, a 97.63% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-09-30 was -$410.00K, a 301.97% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for the quarter ending 2025-06-30 was -$682.00K, a 145.59% decline year-over-year.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2025 was -$177.00K, a 104.32% decline from fiscal 2024.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2024 was $4.10M, a 37.30% decline from fiscal 2023.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2023 was $6.54M, a 46.14% decline from fiscal 2022.
- CONMED CORPORATION other comprehensive income (loss), cash flow hedge, gain (loss), reclassification, after tax for fiscal 2022 was $12.14M.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $551.00K 10-Q · filed 2026-07-29 | $489.00K 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$378.00K derived: sum of 2 quarters · filed 2026-02-17 | -$1.06M derived: sum of 3 quarters · filed 2026-07-29 | -$177.00K 10-K · filed 2026-02-17 |
| 2025-09-30 | -$410.00K 10-Q · filed 2025-11-06 | -$1.09M derived: sum of 2 quarters · filed 2026-07-29 | -$209.00K 10-Q · filed 2025-11-06 | $1.14M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$682.00K 10-Q · filed 2026-07-29 | $202.00K 10-Q · filed 2026-07-29 | $1.55M derived: sum of 3 quarters · filed 2026-07-29 | $1.75M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $883.00K 10-Q · filed 2025-05-01 | $2.23M derived: sum of 2 quarters · filed 2026-02-17 | $2.44M derived: sum of 3 quarters · filed 2026-02-17 | $3.93M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.55M derived: sum of 2 quarters · filed 2026-02-17 | $3.05M derived: sum of 3 quarters · filed 2026-02-17 | $4.10M 10-K · filed 2026-02-17 |
| 2024-09-30 | $203.00K 10-Q · filed 2025-11-06 | $1.70M derived: sum of 2 quarters · filed 2025-11-06 | $2.75M 10-Q · filed 2025-11-06 | $4.71M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $1.50M 10-Q · filed 2025-07-31 | $2.55M 10-Q · filed 2025-07-31 | $4.50M derived: sum of 3 quarters · filed 2026-02-17 | $6.46M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $1.05M 10-Q · filed 2025-05-01 | $3.01M derived: sum of 2 quarters · filed 2026-02-17 | $4.96M derived: sum of 3 quarters · filed 2026-02-17 | $6.54M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $3.91M derived: sum of 2 quarters · filed 2026-02-17 | $5.49M derived: sum of 3 quarters · filed 2026-02-17 | $6.54M 10-K · filed 2026-02-17 |
| 2023-09-30 | $1.95M 10-Q · filed 2024-10-31 | $3.54M derived: sum of 2 quarters · filed 2024-10-31 | $4.58M 10-Q · filed 2024-10-31 | $8.59M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $1.58M 10-Q · filed 2024-08-01 | $2.63M 10-Q · filed 2024-08-01 | $6.63M derived: sum of 3 quarters · filed 2025-02-18 | $10.66M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $1.05M 10-Q · filed 2024-04-25 | $5.05M derived: sum of 2 quarters · filed 2025-02-18 | $9.08M derived: sum of 3 quarters · filed 2025-02-18 | $11.81M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $4.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $8.03M derived: sum of 2 quarters · filed 2025-02-18 | $10.76M derived: sum of 3 quarters · filed 2025-02-18 | $12.14M 10-K · filed 2025-02-18 |
| 2022-09-30 | $4.03M 10-Q · filed 2023-10-26 | $6.76M derived: sum of 2 quarters · filed 2023-10-26 | $8.13M 10-Q · filed 2023-10-26 | $8.02M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $2.73M 10-Q · filed 2023-07-27 | $4.11M 10-Q · filed 2023-07-27 | $3.99M derived: sum of 3 quarters · filed 2024-02-28 | $3.49M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.38M 10-Q · filed 2023-04-27 | $1.26M derived: sum of 2 quarters · filed 2024-02-28 | $761.00K derived: sum of 3 quarters · filed 2024-02-28 | -$462.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$617.00K derived: sum of 2 quarters · filed 2024-02-28 | -$1.84M derived: sum of 3 quarters · filed 2024-02-28 | -$3.04M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$499.00K 10-Q · filed 2022-10-27 | -$1.72M derived: sum of 2 quarters · filed 2022-10-27 | -$2.92M 10-Q · filed 2022-10-27 | -$3.01M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | -$1.22M 10-Q · filed 2022-07-28 | -$2.42M 10-Q · filed 2022-07-28 | -$2.51M derived: sum of 3 quarters · filed 2023-02-21 | -$2.17M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | -$1.20M 10-Q · filed 2022-05-05 | -$1.29M derived: sum of 2 quarters · filed 2023-02-21 | -$950.00K derived: sum of 3 quarters · filed 2023-02-21 | -$1.01M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | -$89.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $251.00K derived: sum of 2 quarters · filed 2023-02-21 | $193.00K derived: sum of 3 quarters · filed 2023-02-21 | $1.04M 10-K · filed 2023-02-21 |
| 2020-09-30 | $340.00K 10-Q · filed 2021-10-28 | $282.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.13M 10-Q · filed 2021-10-28 | $2.96M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | -$58.00K 10-Q · filed 2021-07-29 | $794.00K 10-Q · filed 2021-07-29 | $2.63M derived: sum of 3 quarters · filed 2022-02-22 | $4.42M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $852.00K 10-Q · filed 2021-04-29 | $2.68M derived: sum of 2 quarters · filed 2022-02-22 | $4.47M derived: sum of 3 quarters · filed 2022-02-22 | $6.17M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.62M derived: sum of 2 quarters · filed 2022-02-22 | $5.32M derived: sum of 3 quarters · filed 2022-02-22 | $6.53M 10-K · filed 2022-02-22 |
| 2019-09-30 | $1.79M 10-Q · filed 2020-10-29 | $3.48M derived: sum of 2 quarters · filed 2020-10-29 | $4.70M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | $1.69M 10-Q · filed 2020-07-30 | $2.91M 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $1.21M 10-Q · filed 2020-04-30 | |||
| 2018-12-31 | -$692.00K 10-K · filed 2021-02-22 | |||
| 2017-12-31 | -$453.00K 10-K · filed 2020-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |